Gene · 779
Papers2,128
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 2,128
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Voltage-Gated Ca2+-Channel α1-Subunit de novo Missense Mutations: Gain or Loss of Function - Implications for Potential Therapies. | Front Synaptic Neurosci | 2021 | 33746731 | PubTator, text mining | PubMed |
| Identification of disease treatment mechanisms through the multiscale interactome. | Nat Commun | 2021 | 33741907 | PubTator, text mining | PubMed |
| Novel roles for voltage-gated T-type Ca2+ and ClC-2 channels in phagocytosis and angiogenic factor balance identified in human iPSC-derived RPE. | FASEB J | 2021 | 33724552 | PubTator, text mining | PubMed |
| Gain-of-Function STIM1 L96V Mutation Causes Myogenesis Alteration in Muscle Cells From a Patient Affected by Tubular Aggregate Myopathy. | Front Cell Dev Biol | 2021 | 33718371 | PubTator, text mining | PubMed |
| Voltage-Gated Ca2+ Channels in Dopaminergic Substantia Nigra Neurons: Therapeutic Targets for Neuroprotection in Parkinson's Disease? | Front Synaptic Neurosci | 2021 | 33716705 | PubTator, text mining | PubMed |
| Cigarettes Make You Weak: RANKL/RANK Link Changes in Muscle and Bone. | Am J Respir Cell Mol Biol | 2021 | 33711242 | PubTator, text mining | PubMed |
| Transient Receptor Potential Canonical Channels in Health and Disease: A 2020 Update. | Cells | 2021 | 33668918 | PubTator, text mining | PubMed |
| Evaluating next-generation sequencing in neuromuscular diseases with neonatal respiratory distress. | Eur J Paediatr Neurol | 2021 | 33667896 | PubTator, text mining | PubMed |
| The life cycle of voltage-gated Ca2+ channels in neurons: an update on the trafficking of neuronal calcium channels. | Neuronal Signal | 2021 | 33664982 | PubTator, text mining | PubMed |
| The Role of Nutrition and Physical Activity as Trigger Factors of Paralytic Attacks in Primary Periodic Paralysis. | J Neuromuscul Dis | 2021 | 33646174 | PubTator, text mining | PubMed |
| Effect of differentiation, de novo innervation, and electrical pulse stimulation on mRNA and protein expression of Na+,K+-ATPase, FXYD1, and FXYD5 in cultured human skeletal muscle cells. | PLoS One | 2021 | 33635930 | PubTator, text mining | PubMed |
| The mechanism of ions in pulmonary hypertension. | Pulm Circ | 2021 | 33614016 | PubTator, text mining | PubMed |
| Actionable pharmacogenetic variants in Hong Kong Chinese exome sequencing data and projected prescription impact in the Hong Kong population. | PLoS Genet | 2021 | 33600428 | PubTator, text mining | PubMed |
| Janus 3D printed dynamic scaffolds for nanovibration-driven bone regeneration. | Nat Commun | 2021 | 33589620 | PubTator, text mining | PubMed |
| Myogenesis modelled by human pluripotent stem cells: a multi-omic study of Duchenne myopathy early onset. | J Cachexia Sarcopenia Muscle | 2021 | 33586340 | PubTator, text mining | PubMed |
| A Review of Genetic and Physiological Disease Mechanisms Associated With Cav1 Channels: Implications for Incomplete Congenital Stationary Night Blindness Treatment. | Front Genet | 2021 | 33584831 | PubTator, text mining | PubMed |
| A New Computer Model for Evaluating the Selective Binding Affinity of Phenylalkylamines to T-Type Ca2+ Channels. | Pharmaceuticals (Basel) | 2021 | 33578931 | PubTator, text mining | PubMed |
| Sport Performance and Manual Therapies: A Review on the Effects on Mitochondrial, Sarcoplasmatic and Ca2+ Flux Response. | Healthcare (Basel) | 2021 | 33572071 | PubTator, text mining | PubMed |
| Genetic Modifiers of Hereditary Neuromuscular Disorders and Cardiomyopathy. | Cells | 2021 | 33567613 | PubTator, text mining | PubMed |
| Relevance of pathogenicity prediction tools in human RYR1 variants of unknown significance. | Sci Rep | 2021 | 33564012 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/779/papers?page=33